Haneen Husham Fadhil
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Haneen Husham Fadhil has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Basil Abdulmahdi Salih
Department of Chemistry, College of Science, University of Basrah, Basrah 61004, Iraq
1 shared publication - Faris Abdulridha Jassim Al-Doghachi
Chemistry Department, Faculty of Science, University of Basrah, 61004, Basrah, Iraq
1 shared publication - Jubran Khaleel Hasan
Department of Clinical Pharmacy, College of Pharmacy, University of Basrah, Basrah, Iraq
1 shared publication - Rana Dawood Salman
Department of Clinical Laboratory Sciences, College of Pharmacy, University of Basrah, Basrah, Iraq
1 shared publication - Yun Hin Taufiq-Yap
Catalysis Science and Technology Research Centre, Faculty of Science, Universiti Putra Malaysia, UPM, Serdang, Malaysia
1 shared publication
Latest Publications
- Open Access
- 30 December 2025
- Published by University of Rzeszow in European Journal of Clinical and Experimental Medicine
- Vol. 23 (4) , 994–999
Serum leptin and glucagon-like peptide-1 levels in diabetic patients with end-stage renal disease on hemodialysis ‒ a cross-sectional study in Iraqi patients
Introduction and aim. Diabetic kidney disease (DKD), a common complication of type 2 diabetes mellitus, is the leading cause of end-stage renal disease (ESRD). This study aimed to evaluate differences in serum leptin and glucagon-like peptide-1 (GLP-1) levels between diabetic ESRD patients undergoing hemodialysis and healthy controls. Material and methods. A cross-sectional observational study was conducted involving 65 participants: 31 type 2 diabetic patients with ESRD on hemodialysis and 34 healthy controls. Serum leptin and GLP-1 concentrations were measured using enzyme-linked immunosorbent assays. Results. Patients with ESRD exhibited significantly higher serum leptin levels (1.7±1.0 ng/mL) compared to controls (1.4±0.7 ng/mL; p=0.001), and significantly lower GLP-1 levels (19.6±11.2 pmol/L vs. 37.0±25.7 pmol/L; p=0.001). Conclusion. Elevated leptin levels and reduced GLP-1 concentrations in diabetic ESRD patients suggest a potential role of these biomarkers in renal injury and metabolic regulation. The findings highlight the therapeutic promise of GLP-1 receptor agonists in this population.
- 30 December 2025
- Published by University of Rzeszow in European Journal of Clinical and Experimental Medicine
- Vol. 23 (4) , 994–999
Open AccessSerum leptin and glucagon-like peptide-1 levels in diabetic patients with end-stage renal disease on hemodialysis ‒ a cross-sectional study in Iraqi patients
Introduction and aim. Diabetic kidney disease (DKD), a common complication of type 2 diabetes mellitus, is the leading cause of end-stage renal disease (ESRD). This study aimed to evaluate differences in serum leptin and glucagon-like peptide-1 (GLP-1) levels between diabetic ESRD patients undergoing hemodialysis and healthy controls. Material and methods. A cross-sectional observational study was conducted involving 65 participants: 31 type 2 diabetic patients with ESRD on hemodialysis and 34 healthy controls. Serum leptin and GLP-1 concentrations were measured using enzyme-linked immunosorbent assays. Results. Patients with ESRD exhibited significantly higher serum leptin levels (1.7±1.0 ng/mL) compared to controls (1.4±0.7 ng/mL; p=0.001), and significantly lower GLP-1 levels (19.6±11.2 pmol/L vs. 37.0±25.7 pmol/L; p=0.001). Conclusion. Elevated leptin levels and reduced GLP-1 concentrations in diabetic ESRD patients suggest a potential role of these biomarkers in renal injury and metabolic regulation. The findings highlight the therapeutic promise of GLP-1 receptor agonists in this population.
- Open Access
- 29 May 2025
- Published by Universitas Gadjah Mada in Indonesian Journal of Chemistry
- Vol. 25 (3) , 864-877
Synthesis, Characterization, and Anti-Breast Cancer Properties of Cu(II) Complexes with Schiff Base and Azo Dye Ligands
This article focuses on the synthesis of three Schiff base ligands derived from 2-hydroxybenzaldehyde (B: BBr, BOCH3, BNO2) and three azo dye ligands derived from naphthol (A: ABr, AOCH3, ANO2), followed by the preparation of copper(II) complexes with these six ligands in a 1:2 (metal:ligand) ratio. The ligands and complexes were characterized by using 1H-NMR, 13C-NMR, FTIR, UV-vis, and ESI-MS. Thermogravimetric and differential thermal analyses of the copper complexes indicated the absence of water molecules in the crystalline coordination, demonstrating high thermal stability. The findings confirmed the formation of square-planar copper complexes. The biological activity of the complexes was evaluated on breast cancer and healthy cells using the MTT assay at different concentrations. The IC50 analysis showed that CuABr, CuBBr, and CuAOCH3 had a significantly more substantial cytotoxic effect on cancer cells than on healthy cells. CuBOCH3 and CuBNO2 also exhibited notable selectivity toward cancer cells, whereas CuANO2 was more toxic to normal cells. These findings highlight the potential of CuABr, CuBBr, and CuAOCH3 as promising candidates for further development in targeted breast cancer therapy.
- 29 May 2025
- Published by Universitas Gadjah Mada in Indonesian Journal of Chemistry
- Vol. 25 (3) , 864-877
Open AccessSynthesis, Characterization, and Anti-Breast Cancer Properties of Cu(II) Complexes with Schiff Base and Azo Dye Ligands
This article focuses on the synthesis of three Schiff base ligands derived from 2-hydroxybenzaldehyde (B: BBr, BOCH3, BNO2) and three azo dye ligands derived from naphthol (A: ABr, AOCH3, ANO2), followed by the preparation of copper(II) complexes with these six ligands in a 1:2 (metal:ligand) ratio. The ligands and complexes were characterized by using 1H-NMR, 13C-NMR, FTIR, UV-vis, and ESI-MS. Thermogravimetric and differential thermal analyses of the copper complexes indicated the absence of water molecules in the crystalline coordination, demonstrating high thermal stability. The findings confirmed the formation of square-planar copper complexes. The biological activity of the complexes was evaluated on breast cancer and healthy cells using the MTT assay at different concentrations. The IC50 analysis showed that CuABr, CuBBr, and CuAOCH3 had a significantly more substantial cytotoxic effect on cancer cells than on healthy cells. CuBOCH3 and CuBNO2 also exhibited notable selectivity toward cancer cells, whereas CuANO2 was more toxic to normal cells. These findings highlight the potential of CuABr, CuBBr, and CuAOCH3 as promising candidates for further development in targeted breast cancer therapy.